Recent progress in cell therapy for basal ganglia disorders with emphasis on menstrual blood transplantation in stroke

Neuroscience and Biobehavioral Reviews

Volumn 36, Issue 1, 2012, Pages 177-190

  Rodrigues, Maria Carolina Oliveira ^a,b   Voltarelli, Julio ^b   Sanberg, Paul R ^a   Allickson, Julie G ^c   Kuzmin Nichols, Nicole ^d   Garbuzova Davis, Svitlana ^a   Borlongan, Cesar V ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c Cryo Cell International Inc   (United States)

^d Saneron CCEL Therapeutics Inc   (United States)

Author keywords

Basal ganglia disorders; Cell based therapy; Endometrium derived stem cells; Huntington's disease; Menstrual blood stem cells; Parkinson's disease; Stroke

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

BASAL GANGLION; BLEEDING DISORDER; BRAIN ISCHEMIA; CAUSE OF DEATH; CELL DEATH; CELL THERAPY; CELL TRANSPLANTATION; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROVASCULAR DISEASE; EXTRAPYRAMIDAL SYNDROME; HUMAN; HUNTINGTON CHOREA; MENSTRUAL BLOOD TRANSPLANTATION; MULTIPLE SCLEROSIS; PARKINSON DISEASE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; SPINAL CORD INJURY; STEM CELL TRANSPLANTATION; STROKE; UNITED STATES;

BASAL GANGLIA DISEASES; CELL PROLIFERATION; HUMANS; MENSTRUATION; MULTIPOTENT STEM CELLS; NEOVASCULARIZATION, PHYSIOLOGIC; STEM CELL TRANSPLANTATION; TISSUE THERAPY;

EID: 82855175251     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2011.05.010     Document Type: Review

References (218)

1. Abematsu M., Tsujimura K., Yamano M., et al. Neurons derived from transplanted neural stem cells restore disrupted neuronal circuitry in a mouse model of spinal cord injury. J. Clin. Invest. 2010, 120:3255-3266.
2. Alexandrov A.V., Burgin W.S., Demchuk A.M., El-Mitwalli A., Grotta J.C. Speed of intracranial clot lysis with intravenous tissue plasminogen activator therapy, sonographic classification and short-term improvement. Circulation 2001, 103:2897-2902.
3. Alexi T., Borlongan C.V., Faull R.L., et al. Neuroprotective strategies for basal ganglia degeneration: Parkinson's and Huntington's diseases. Prog. Neurobiol. 2000, 60:409-470.
4. Amor S., Puentes F., Baker D., van der Valk P. Inflammation in neurodegenerative diseases. Immunology 2010, 129:154-169.
5. Androutsellis-Theotokis A., Rueger M.A., Park D.M. Angiogenic factors stimulate growth of adult neural stem cells. PLoS One 2010, 5:e9414.
6. Antonucci I., Stuppia L., Kaneko Y., et al. Amniotic fluid as rich source of mesenchymal stromal cells for transplantation therapy. Cell Transplant. 2010, 10.3727/096368910X539074.
7. Arboleda-Velasquez J.F., Zhou Z., Shin H.K., et al. Linking Notch signaling to ischemic stroke. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:4856-4861.
8. Appel S.H., Engelhardt J.I., Henkel J.S., et al. Hematopoietic stem cell transplantation in patients with sporadic amyotrophic lateral sclerosis. Neurology 2008, 71:1326-1334.
9. Arenas E. Towards stem cell replacement therapies for Parkinson's disease. Biochem. Biophys. Res. Commun. 2010, 396:152-156.
10. Asplund K., Stegmayr B., Peltonen M. From the twentieth to the twenty-first century: a public health perspective on stroke. Cerebrovascular Disease Pathophysiology, Diagnosis, and Management 1998, 901-918. Blackwell Science, MA. M.D. Ginsberg, J. Bogousslavsky (Eds.).
11. Atochin D.N., Fisher D., Demchenko I.T., Thom S.R. Neutrophil seques-tration and the effect of hyperbaric oxygen in a rat model of temporary middle cerebral artery occlusion. Undersea Hyperb. Med. 2000, 27:185-190.
12. Aubry L., Peschanski M., Perrier A.L. Human embryonic-stem-cell-derived striatal graft for Huntington's disease cell therapy. Med. Sci. (Paris) 2009, 25:333-335.
13. Baraniak P.R., McDevitt T.C. Stem cell paracrine actions and tissue regeneration. Regen. Med. 2010, 5:121-143.
14. Bai L., Lennon D.P., Eaton V., et al. Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis. Glia 2009, 57:1192-1203.
15. Banerjee S., Williamson D., Habib N., Gordon M., Chataway J. Human stem cell therapy in ischaemic stroke: a review. Age Ageing 2011, 40:7-13.
16. Bang O.Y., Lee J.S., Lee P.H., Lee G. Autologous mesenchymal stem cell transplantation in stroke patients. Ann. Neurol. 2005, 57:874-882.
17. Banwell S., Sena E.S., Macleod M.R. Systematic review and stratified meta-analysis of the efficacy of interleukin-1 receptor antagonist in animal models of stroke. J. Stroke Cerebrovasc. Dis. 2009, 18:269-276.
18. Barhum Y., Gai-Castro S., Bahat-Stromza M., et al. Intracerebroventricular transplantation of human mesenchymal stem cells induced to secrete neurotrophic factors attenuates clinical symptoms in a mouse model of multiple sclerosis. J. Mol. Neurosci. 2010, 41:129-137.
19. Barzilay R., Levy Y.S., Melamed E., Offen D. Adult stem cells for neuronal repair. Isr. Med. Assoc. J. 2006, 8:61-66.
20. Björklund A., Stenevi U., Dunnett S.B., Iversen S.D. Functional reactivation of the deafferented neostriatum by nigral transplants. Nature 1981, 289:497-499.
21. Björklund A., Lindvall O. Cell replacement therapies for central nervous system disorders. Nat. Neurosci. 2000, 3:537-544.
22. Björklund A., Cenci M.A. Recent advances in Parkinson's disease: basic research. Prog. Brain Res. 2010, 183:ix-x.
23. Boltze J., Kowalski I., Geiger K., et al. Experimental treatment of stroke in spontaneously hypertensive rats by CD34+ and CD34- cord blood cells. Ger. Med. Sci. 2005, 3. Doc 09.
24. Borlongan C.V., Cameron D.F., Saporta S., Sanberg P.R. Intracerebral transplantation of testis-derived sertoli cells promotes functional recovery in female rats with 6-hydroxydopamine-induced hemiparkinsonism. Exp. Neurol. 1997, 148:388-392.
25. Borlongan C.V., Koutouzis T.K., Poulos S.G., Saporta S., Sanberg P.R. Bilateral fetal striatal grafts in the 3-nitropropionic acid-induced hypoactive model of Huntington's disease. Cell Transplant. 1998, 7:131-137.
26. Borlongan C.V., Tajima Y., Trojanowski J.Q., Lee V.M., Sanberg P.R. Transplantation of cryopreserved human embryonal carcinoma-derived neurons (NT2N cells) promotes functional recovery in ischemic rats. Exp. Neurol. 1998, 149:310-321.
27. Borlongan C.V., Stahl C.E., Freeman T.B., Hauser R.A., Sanberg P.R. Neural transplantation and Huntington's disease, what can we learn from the 3-nitropionic acid model. Mitochondrial Inhibitors and Neurodegenerative Disorders 1999, 275-292. Humana Press, NJ. P.R. Sanberg, H. Nishino, C.V. Borlongan (Eds.).
28. Borlongan C.V., Hadman M., Sanberg C.D., Sanberg P.R. Central nervous system entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke. Stroke 2004, 35:2385-2389.
29. Borlongan C.V., Kaneko Y., Maki M., et al. Menstrual blood cells display stem cell-like phenotypic markers and exert neuroprotection following transplantation in experimental stroke. Stem Cells Dev. 2010, 19:439-451.
30. Bratincsák A., Brownstein M.J., Cassiani-Ingoni R., et al. CD45-positive blood cells give rise to uterine epithelial cells in mice. Stem Cells 2007, 25:2820-2826.
31. Brochard V., Combadière B., Prigent A., et al. Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. J. Clin. Invest. 2009, 119:182-192.
32. Burt R.K., Loh Y., Cohen B., et al. Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study. Lancet Neurol. 2009, 8:244-253.
33. Capetian P., Knoth R., Maciaczyk J., et al. Histological findings on fetal striatal grafts in a Huntington's disease patient early after transplantation. Neuroscience 2009, 160:661-675.
34. Carbajal K.S., Schaumburg C., Strieter R., Kane J., Lane T.E. Migration of engrafted neural stem cells is mediated by CXCL12 signaling through CXCR4 in a viral model of multiple sclerosis. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:11068-11073.
35. Carpenter C.R., Keim S.M., Milne W.K., Meurer W.J., Barsan W.G. The best evidence in emergency medicine investigator group. Thrombolytic therapy for acute ischemic stroke beyond 3h. J. Emerg. Med. 2011, 40:82-92.
36. Centers for Disease Control and Prevention (CDC) Prevalence of disabilities and associated health conditions among adults, United States. MMWR Morb. Mortal. Wkly. Rep. 1999, 50:120-125.
37. Cervelló I., Gil-Sanchis C., Mas A., et al. Human endometrial side population cells exhibit genotypic, phenotypic and functional features of somatic stem cells. PLoS One 2010, 5:e10964.
38. Chan R.W., Schwab K.E., Gargett C.E. Clonogenicity of human endometrial epithelial and stromal cells. Biol. Reprod. 2004, 70:1738-1750.
39. Chen J., Sanberg P.R., Li Y., et al. Intravenous administration of umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke 2001, 32:2682-2688.
40. Cho N.H., Park Y.K., Kim Y.T., Yang H., Kim S.K. Lifetime expression of stem cell markers in the uterine endometrium. Fertil. Steril. 2004, 81:403-407.
41. Connolly E.S., Winfree C.J., Springer T.A., et al. Cerebral pro-tection in homozygous null ICAM-1 mice after middle cerebral artery occlusion. Role of neutrophil adhesion in the pathogenesis of stroke. J. Clin. Invest. 1996, 97:209-216.
42. Connor B., Dragunow M. The role of neuronal growth factors in neurodegenerative disorders of the human brain. Brain Res. Brain Res. Rev. 1998, 27:1-39.
43. Constantin G., Marconi S., Rossi B., et al. Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis. Stem Cells 2009, 27:2624-2635.
44. Corti S., Nizzardo M., Nardini M., et al. Systemic transplantation of c-kit+ cells exerts a therapeutic effect in a model of amyotrophic lateral sclerosis. Hum. Mol. Genet. 2010, 19:3782-3796.
45. Cronin C.A. Intravenous tissue plasminogen activator for stroke, a review of the ECASS III results in relation to prior clinical trials. J. Emerg. Med. 2010, 38:99-105.
46. Cui C.H., Uyama T., Miyado K., et al. Menstrual blood-derived cells confer human dystrophin expression in the murine model of Duchenne muscular dystrophy via cell fusion and myogenic transdifferentiation. Mol. Biol. Cell 2007, 18:1586-1594.
47. Cui Y.F., Hargus G., Xu J.C., et al. Embryonic stem cell-derived L1 overexpressing neural aggregates enhance recovery in Parkinsonian mice. Brain 2010, 133:189-204.
48. Daar A.S., Bhatt A., Court E., Singer P.A. Stem cell research and transplantation: science leading ethics. Transplant. Proc. 2004, 36:2504-2506.
49. Deda H., Inci M.C., Kürekçi A.E., et al. Treatment of amyotrophic lateral sclerosis patients by autologous bone marrow-derived hematopoietic stem cell transplantation: a 1-year follow-up. Cytotherapy 2009, 11:18-25.
50. Deshpande D.M., Kim Y.S., Martinez T., et al. Recovery from paralysis in adult rats using embryonic stem cells. Ann. Neurol. 2006, 60:32-44.
51. Detante O., Moisan A., Dimastromatteo J., et al. Intravenous administration of 99mTc-HMPAO-labeled human mesenchymal stem cells after stroke: in vivo imaging and biodistribution. Cell Transplant. 2009, 18:1369-1379.
52. Dey N.D., Bombard M.C., Roland B.P., et al. Genetically engineered mesenchymal stem cells reduce behavioral deficits in the YAC128 mouse model of Huntington's disease. Behav. Brain Res. 2010, 214:193-200.
53. Drago H., Marín H., Sturla F., et al. The next generation of burns treatment, intelligent films and matrix, controlled enzymatic debridement, and adult stem cells. Transplant. Proc. 2010, 42:345-349.
54. Einstein O., Friedman-Levi Y., Grigoriadis N., Ben-Hur T. Transplanted neural precursors enhance host brain-derived myelin regeneration. J. Neurosci. 2009, 29:15694-15702.
55. Emsley C.A., Smith C.J., Tyrrell P.J., Hopkins S.J. Inflammation in acute ischemic stroke and its relevance to stroke critical care. Neurocrit. Care 2008, 9:125-138.
56. Enlimomab Acute Stroke Trial Investigators Use of anti-ICAM-1 therapy in ischemic stroke: results of the Enlimomab Acute Stroke Trial. Neurology 2001, 57:1428-1434.
57. Ende N., Chen R. Parkinson's disease mice and human umbilical cord blood. J. Med. 2002, 33:173-180.
58. Erceg S., Ronaghi M., Oria M., et al. Transplanted oligodendrocytes and motoneuron progenitors generated from human embryonic stem cells promote locomotor recovery after spinal cord transection. Stem Cells 2010, 28:1541-1549.
59. Erdogan B., Bavbek M., Sahin I.F. Fetal allogeneic umbilical cord cell transplantation improves motor function in spinal cord-injured rats. Turk. Neurosurg. 2010, 20:286-294.
60. Erlandsson A., Lin A., Yu F., Morshead C.M. Immunosuppression promotes endogenous neural stem and progenitor cell migration and tissue regeneration after ischemic injury. Exp. Neurol. 2010, 10.1016/j.expneurol.2010.05.018.
61. Fan H., Li L., Zhang X., Liu Y., Yang C., Yang Y., Yin J. Oxymatrine downregulates TLR4, TLR2, MyD88, and NF-kappaB and protects rat brains against focal ischemia. Mediators Inflamm. 2009, 2009:704-706.
62. Fan Y., Shen F., Frenzel T., et al. Endothelial progenitor cell transplantation improves long-term stroke outcome in mice. Ann. Neurol. 2010, 67:488-497.
63. Faraji J., Lehmann H., Metz G.A., Sutherland R.J. Stress and corticosterone enhance cognitive recovery from hippocampal stroke in rats. Neurosci. Lett. 2009, 462:248-252.
64. Fassas A., Passweg J.R., Anagnostopoulos A., et al. Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study. J. Neurol. 2002, 249:1088-1097.
65. Faulkner J.R., Herrmann J.E., Woo M.J., et al. Reactive astrocytes protect tissue and preserve function after spinal cord injury. J. Neurosci. 2004, 24:2143-2155.
66. Felfly H., Muotri A., Yao H., Haddad G.G. Hematopoietic stem cell transplantation protects mice from lethal stroke. Exp. Neurol. 2010, 225:284-293.
67. Feron F., Perry C., Cochrane J., et al. Autologous olfactory ensheathing cell transplantation in human spinal cord injury. Brain 2005, 128:2951-2960.
68. Fricker-Gates R.A., Gates M.A. Stem cell-derived dopamine neurons for brain repair in Parkinson's disease. Regen. Med. 2010, 5:267-278.
69. Friling S., Andersson E., Thompson L.H., et al. Efficient production of mesencephalic dopamine neurons by Lmx1a expression in embryonic stem cells. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:7613-7618.
70. Fujiwara Y., Tanaka N., Ishida O., et al. Intravenously injected neural progenitor cells of transgenic rats can migrate to the injured spinal cord and differentiate into neurons, astrocytes and oligodendrocytes. Neurosci. Lett. 2004, 366:287-291.
71. Gallina P., Paganini M., Lombardini L., et al. Human striatal neuroblasts develop and build a striatal-like structure into the brain of Huntington's disease patients after transplantation. Exp. Neurol. 2010, 222:30-41.
72. Gamez J., Carmona F., Raguer N., et al. Cellular transplants in amyotrophic lateral sclerosis patients: an observational study. Cytotherapy 2010, 12:669-677.
73. Garbuzova-Davis S., Willing A.E., Zigova T., et al. Intravenous administration of human umbilical cord blood cells in a mouse model of amyotrophic lateral sclerosis distribution, migration and differentiation. J. Hematot. Stem Cell Res. 2003, 12:255-270.
74. Garbuzova-Davis S., Willing A.E., Saporta S., et al. Multiple transplants of hNT cells into the spinal cord of SOD1 mouse model of familial amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 2006, 7:221-226.
75. Garbuzova-Davis S., Sanberg C.D., Kuzmin-Nichols N., et al. Human umbilical cord blood treatment in a mouse model of ALS: optimization of cell dose. PLoS One 2008, 3:e2494.
76. Gargett C.E., Schwab K.E., Zillwood R.M., Nguyen H.P., Wu D. Isolation and culture of epithelial progenitors and mesenchymal stem cells from human endometrium. Biol. Reprod. 2009, 80:1136-1145.
77. Gelderblom M., Leypoldt F., Steinbach K., et al. Temporal and spatial dynamics of cerebral immune cell accumulation in stroke. Stroke 2009, 40:1849-1857.
78. Gerbal-Chaloin S., Duret C., Raulet E., et al. Isolation and culture of adult human liver progenitor cells, in vitro differentiation to hepatocyte-like cells. Methods Mol. Biol. 2010, 640:247-260.
79. Glavaski-Joksimovic A., Virag T., Chang Q.A., et al. Reversal of dopaminergic degeneration in a parkinsonian rat following micrografting of human bone marrow-derived neural progenitors. Cell Transplant. 2009, 18:801-814.
80. Glavaski-Joksimovic A., Virag T., Mangatu T.A., et al. Glial cell line-derived neurotrophic factor-secreting genetically modified human bone marrow-derived mesenchymal stem cells promote recovery in a rat model of Parkinson's disease. J. Neurosci. Res. 2010, 88:2669-2681.
81. Govaert J.A., Swijnenburg R.J., Schrepfer S., et al. Poor functional recovery after transplantation of diabetic bone marrow stem cells in ischemic myocardium. J. Heart Lung Transplant. 2009, 28:1158-1165.
82. Gout O., Dubois-Dalcq M. Directed migration of transplanted glial cells toward a spinal cord demyelinating lesion. Int. J. Dev. Neurosci. 1993, 11:613-623.
83. Green R.A., Odergren T., Ashwood T. Animal models of stroke: do they have value for discovering neuroprotective agents?. Trends Pharmacol. Sci. 2003, 24:402-408.
84. Gu R., Hou X., Pang R., Li L., Chen F., Geng J., Xu Y., Zhang C. Human adipose-derived stem cells enhance the glutamate uptake function of GLT1 in SOD1(G93A)-bearing astrocytes. Biochem. Biophys. Res. Commun. 2010, 393:481-486.
85. Guzman R., Meyer M., Lovblad K.O., et al. Striatal grafts in a rat model of Huntington's disease, time course comparison of MRI and histology. Exp. Neurol. 1999, 156:180-190.
86. Hacke W., Kaste M., Fieschi C., et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995, 274:1017-1025.
87. Hacke W., Kaste M., Bluhmki E., et al. Thrombolysis with alteplase 3 to 4.5h after acute ischemic stroke. N. Engl. J. Med. 2008, 359:1317-1329.
88. Hagell P., Brundin P. Cell survival and clinical outcome following intrastriatal transplantation in Parkinson's disease. J. Neuropathol. Exp. Neurol. 2001, 60:741-752.
89. Hamerschlak N., Rodrigues M., Moraes D.A., et al. Brazilian experience with two conditioning regimens in patients with multiple sclerosis: BEAM/horse ATG and CY/rabbit ATG. Bone Marrow Transplant. 2010, 45:239-248.
90. Hefti F. Pharmacology of neurotrophic factors. Annu. Rev. Pharmacol. Toxicol. 1997, 37:239-267.
91. Hemendinger R., Wang J., Malik S., et al. Sertoli cells improve survival of motor neurons in SOD1 transgenic mice, a model of amyotrophic lateral sclerosis. Exp. Neurol. 2005, 196:235-243.
92. Hess D.C., Borlongan C.V. Cell-based therapy in ischemic stroke. Expert Rev. Neurother. 2008, 8:1193-1201.
93. Hida N., Nishiyama N., Miyoshi S., et al. Novel cardiac precursor-like cells from human menstrual blood-derived mesenchymal cells. Stem Cells 2008, 26:1695-1704.
94. Hill W.D., Hess D.C., Martin-Studdard A., et al. SDF-1 (CXCL12) is upregulated in the ischemic penumbra following stroke: association with bone marrow cell homing to injury. J. Neuropathol. Exp. Neurol. 2004, 63:84-96.
95. Hu S.L., Luo H.S., Li J.T., et al. Functional recovery in acute traumatic spinal cord injury after transplantation of human umbilical cord mesenchymal stem cells. Crit. Care Med. 2010, 38:2181-2189.
96. Huang H.I., Chen S.K., Ling Q.D., et al. Multilineage differentiation potential of fibroblast-like stromal cells derived from human skin. Tissue Eng. Part A 2010, 16:1491-1501.
97. Hurn P.D., Subramanian S., Parker S.M., et al. T- and B-cell-deficient mice with experimentalstroke have reduced lesion size and inflammation. J. Cereb. Blood Flow Metab. 2007, 27:1798-1805.
98. Hwang D.H., Lee H.J., Park I.H. Intrathecal transplantation of human neural stem cells overexpressing VEGF provide behavioral improvement, disease onset delay and survival extension in transgenic ALS mice. Gene Ther. 2009, 16:1234-1244.
99. Ikegame Y., Yamashita K., Hayashi S.I., et al. Comparison of mesenchymal stem cells from adipose tissue and bone marrow for ischemic stroke therapy. Cytotherapy 2011, 10.3109/14653249.2010.549122.
100. Jablonska A., Kozlowska H., Markiewicz I., Domanska-Janik K., Lukomska B. Transplantation of neural stem cells derived from human cord blood to the brain of adult and neonatal rats. Acta Neurobiol. Exp. 2010, 70:337-350.
101. Jeffery N.D., Lakatos A., Franklin R.J. Autologous olfactory glial cell transplantation is reliable and safe in naturally occurring canine spinal cord injury. J. Neurotrauma 2005, 22:1282-1293.
102. Jiang M., Lv L., Ji H., et al. Induction of pluripotent stem cells transplantation therapy for stroke. Mol. Cell. Biochem. 2011, 10.1007/s11010-011-0806-5.
103. Jin K., Sun Y., Xie L., et al. Comparison of ischemia-directed migration of neural precursor cells after intrastriatal, intraventricular, or intravenous transplantation in the rat. Neurobiol. Dis. 2005, 18:366-374.
104. Jin R., Yang G., Li G. Inflammatory mechanisms in ischemic stroke, role of inflammatory cells. J. Leukoc. Biol. 2010, 87:779-789.
105. Kang S.K., Shin M.J., Jung J.S., Kim Y.G., Kim C.H. Autologous adipose tissue-derived stromal cells for treatment of spinal cord injury. Stem Cells Dev. 2006, 15:583-594.
106. Keimpema E., Fokkens M.R., Nagy Z., et al. Early transient presence of implanted bone marrow stem cells reduces lesion size after cerebral ischaemia in adult rats. Neuropathol. Appl. Neurobiol. 2009, 35:89-102.
107. Kent D.M., Selker H.P., Ruthazer R., Bluhmki E., Hacke W. Can multivariable risk-benefit profiling be used to select treatment-favorable patients for thrombolysis in stroke in the 3- to 6-hour time window?. Stroke 2006, 37:2963-2969.
108. Kern S., Eichler H., Stoeve J., Klüter H., Bieback K. Comparative analysis of mesenchymal stem cells from bone marrow. Umbilical cord blood, or adipose tissue. Stem Cells 2006, 24:1294-1301.
109. Kim H., Kim H.Y., Choi M.R., et al. Dose-dependent efficacy of ALS-human mesenchymal stem cells transplantation into cisterna magna in SOD1-G93A ALS mice. Neurosci. Lett. 2010, 468:190-194.
110. Kim S.Y., Cho H.S., Yang S.H., et al. Soluble mediators from human neural stem cells play a critical role in suppression of T-cell activation and proliferation. J. Neurosci. Res. 2009, 87:2264-2272.
111. Kishk N.A., Gabr H., Hamdy S., et al. Case control series of intrathecal autologous bone marrow mesenchymal stem cell therapy for chronic spinal cord injury. Neurorehabil. Neural Repair 2010, 24:702-708.
112. Kleindorfer D., Lindsell C.J., Brass L., Koroshetz W., Broderick J.P. National US estimates of recombinant tissue plasminogen activator use, ICD-9 codes substantially underestimate. Stroke 2008, 39:924-928.
113. Koh S.H., Kim K.S., Choi M.R., et al. Implantation of human umbilical cord-derived mesenchymal stem cells as a neuroprotective therapy for ischemic stroke in rats. Brain Res. 2008, 229:233-248.
114. Kondziolka D., Wechsler L., Goldstein S., et al. Transplantation of cultured human neuronal cells for patients with stroke. Neurology 2000, 55:565-569.
115. Kriz J. Inflammation in ischemic brain injury, timing is important. Crit. Rev. Neurobiol. 2006, 18:145-157.
116. Le Belle J.E., Caldwell M.E., Svendsen C.N., et al. Improving the survival of human CNS precursor-derived neurons after transplantation. J. Neurosci. Res. 2004, 76:174-183.
117. Lee J.K., Jin H.K., Endo S., et al. Intracerebral transplantation of bone marrow-derived mesenchymal stem cells reduces amyloid-beta deposition and rescues memory deficits in Alzheimer's disease mice by modulation of immune responses. Stem Cells 2010, 28:329-343.
118. Lee S.T., Chu K., Jung K.H., et al. Anti-inflammatory mechanism of intravascular neural stem cell transplantation in haemorrhagic stroke. Brain 2008, 131:616-629.
119. Leu S., Lin Y.C., Yuen C.M., et al. Adipose-derived mesenchymal stem cells markedly attenuate brain infarct size and improve neurological function in rats. J. Transl. Med. 2010, 8:63.
120. Li J.M., Zhu H., Lu S., et al. Migration and differentiation of human mesenchymal stem cells in the normal rat brain. Neurol. Res. 2010, 33:84-92.
121. Li M., Zhang S.Z., Guo Y.W., et al. Human umbilical vein-derived dopaminergic-like cell transplantation with nerve growth factor ameliorates motor dysfunction in a rat model of Parkinson's disease. Neurochem. Res. 2010, 35:1522-1529.
122. Liang J., Zhang H., Hua B., et al. Allogeneic mesenchymal stem cells transplantation in treatment of multiple sclerosis. Mult. Scler. 2009, 15:644-646.
123. Lim H.C., Lee S.T., Chu K., et al. Neuroprotective effect of neural stem cell-conditioned media in in vitro model of Huntington's disease. Neurosci. Lett. 2008, 435:175-180.
124. Linares G., Mayer S.A. Hypothermia for the treatment of ischemic and hemorrhagic stroke. Crit. Care Med. 2009, 37:S243-S249.
125. Lindvall O., Rehnerona S., Brundin P., et al. Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. A detailed account of methodology and a 6-month follow-up. Arch. Neurol. 1989, 46:615-631.
126. Lindvall O., Björklund A. First step towards cell therapy for Huntington's disease. Lancet 2000, 356:1945-1946.
127. Liu Y.P., Lang B.T., Baskaya M.K., Dempsey R.J., Vemuganti R. The potential of neural stem cells to repair stroke-induced brain damage. Acta Neuropathol. 2009, 117:469-480.
128. Lloyd-Jones D., Adams R.J., Brown T.M., et al. Executive summary, heart disease and stroke statistics-2010 update, a report from the American Heart Association. Circulation 2010, 121:948-954.
129. López-González R., Kunckles P., Velasco I. Transient recovery in a rat model of familial amyotrophic lateral sclerosis after transplantation of motor neurons derived from mouse embryonic stem cells. Cell Transplant. 2009, 18:1171-1181.
130. Loughlin A.J., Woodroofe M.N., Cuzner M.L. Modulation of interferon-gamma-induced major histocompatibility complex class II and Fc receptor expression on isolated microglia by transforming growth factor-beta 1, interleukin-4, noradrenaline and glucocorticoids. Immunology 1993, 79:125-130.
131. Luheshi N.M., Rothwell N.J., Brough D. Dual functionality of interleukin-1 family cytokines: implications for anti-interleukin-1 therapy. Br. J. Pharmacol. 2009, 157:1318-1329.
132. Madrazo I., Francobourland R., Ostrosky-Solis F., et al. Fetal homotransplant to the striatum of parkinsonian subjects. Arch. Neurol. 1990, 47:1281-1285.
133. Makar T.K., Bever C.T., Singh I.S., et al. Brain-derived neurotrophic factor gene delivery in an animal model of multiple sclerosis using bone marrow stem cells as a vehicle. J. Neuroimmunol. 2009, 210:40-51.
134. Marler J.R., Tilley B.C., Lu M., et al. Early stroke treatment associated with better outcome, the NINDS rt-PA stroke study. Neurology 2000, 55:1649-1655.
135. Marques S.A., Almeida F.M., Fernandes A.M., et al. Predifferentiated embryonic stem cells promote functional recovery after spinal cord compressive injury. Brain Res. 2010, 1349:115-128.
136. Martinez H.R., Gonzalez-Garza M.T., Moreno-Cuevas J.E., et al. Stem-cell transplantation into the frontal motor cortex in amyotrophic lateral sclerosis patients. Cytotherapy 2009, 11:26-34.
137. Masuda H., Matsuzaki Y., Hiratsu E., et al. Human endometrial stem cells. PLoS One 2010, 5:e10387.
138. Matsukawa N., Yasuhara T., Hara K., et al. Therapeutic targets and limits of minocycline neuroprotection in experimental ischemic stroke. BMC Neurosci. 2009, 10:126.
139. Matsuo Y., Onodera H., Shiga Y., et al. Role of cell adhesion molecules in brain injury after transient middle cerebral artery occlusion in the rat. Brain Res. 1994, 656:344-352.
140. Maurer M.H., Thomas C., Bürgers H.F., Kuschinsky W. Transplantation of adult neural progenitor cells transfected with vascular endothelial growth factor rescues grafted cells in the rat brain. Int. J. Biol. Sci. 2007, 4:1-7.
141. Mazo M., Planat-Bénard V., Abizanda G., et al. Transplantation of adipose derived stromal cells is associated with functional improvement in a rat model of chronic myocardial infarction. Eur. J. Heart Fail. 2008, 10:454-462.
142. Mazzini L., Ferrero I., Luparello V., et al. Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: a phase I clinical trial. Exp. Neurol. 2010, 223:229-237.
143. McCoy M.K., Tansey M.G. TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease. J. Neuroinflammation 2008, 5:45.
144. Meng X., Ichim T.E., Zhong J., et al. Endometrial regenerative cells: a novel stem cell population. J. Transl. Med. 2007, 5:57.
145. Mezey E., Chandross K.J., Harta G., Maki R.A., McKercher S.R. Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. Science 2000, 290:1779-1782.
146. Mitrecić D., Nicaise C., Gajović S., Pochet R. Distribution, differentiation, and survival of intravenously administered neural stem cells in a rat model of amyotrophic lateral sclerosis. Cell Transplant. 2010, 19:537-548.
147. Moghadan F.H., Alaie H., Karbalaie K., et al. Transplantation of primed or unprimed mouse embryonic stem cell-derived neural precursor cells improves cognitive function in Alzheimerian rats. Differentiation 2009, 78:59-68.
148. Moon M.H., Kim S.Y., Kim Y.J., et al. Human adipose tissue-derived mesenchymal stem cells improve postnatal neovascularization in a mouse model of hindlimb ischemia. Cell. Physiol. Biochem. 2006, 17:279-290.
149. Mosna F., Annunziato F., Pizzolo G., Krampera M. Cell therapy for cardiac regeneration after myocardial infarct. Which cell is the best?. Cardiovasc. Hematol. Agents Med. Chem. 2010, 8:227-243.
150. Murphy M.P., Wang H., Patel A.N., et al. Allogeneic endometrial regenerative cells, an " off the shelf solution" for critical limb ischemia?. J. Transl. 2008, 6:45.
151. Nakagami H., Maeda K., Morishita R., et al. Novel autologous cell therapy in ischemic limb disease through growth factor secretion by cultured adipose tissue-derived stromal cells. Arterioscler. Thromb. Vasc. Biol. 2005, 25:2542-2547.
152. Nakagomi N., Nakagomi T., Kubo S., et al. Endothelial cells support survival, proliferation, and neuronal differentiation of transplanted adult ischemia-induced neural stem/progenitor cells after cerebral infarction. Stem Cells 2009, 9:2185-2195.
153. Nefussy B., Artamonov I., Deutsch V., et al. Recombinant human granulocyte-colony stimulating factor administration for treating amyotrophic lateral sclerosis: a pilot study. Amyotroph. Lateral Scler. 2010, 11:187-193.
154. Ouchi Y., Yagi S., Yokokura M., Sakamoto M. Neuroinflammation in the living brain of Parkinson's disease. Parkinsonism Relat. Disord. 2009, 15(Suppl. 3):S200-S204.
155. Ourednik J., Ourednik V., Lynch W.P., Schachner M., Snyder E.Y. Neural stem cells display an inherent mechanism for rescuing dysfunctional neurons. Nat. Biotechnol. 2002, 20:1103-1110.
156. Padykula H.A. Regeneration in the primate uterus, the role of stem cells. Ann. N. Y. Acad. Sci. 1991, 622:47-52.
157. Patel A.N., Park E., Kuzman M., et al. Multipotent menstrual blood stromal stem cells, isolation characterization and differentiation. Cell Transplant. 2008, 17:303-311.
158. Park D.H., Borlongan C.V., Willing A.E., et al. Human umbilical cord blood cell grafts for brain ischemia. Cell Transplant. 2009, 18:985-998.
159. Park D.H., Eve D., Musso J., et al. Inflammation and stem cell migration to the injured brain in higher organisms. Stem Cells Dev. 2009, 18:693-701.
160. Pluchino S., Gritti A., Blezer E., et al. Human neural stem cells ameliorate autoimmune encephalomyelitis in non-human primates. Ann. Neurol. 2009, 66:343-354.
161. Poliachenko Iu.V., Driuk M.F., Dombrovs'ky D. Ultrastructural changes of vascular endothelium in patients with chronic ischemia of the extremities after conduction of multipotent stromal cells from adipose tissue transplantation. Klin. Khir. 2010, 6:50-53.
162. Prianishnikov V.A. On the concept of stem cell and a model of functional-morphological structure of the endometrium. Contraception 1978, 18:213-223.
163. Ra J.C., Shin I.S., Kim S.H., et al. Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans. Stem Cells Dev. 2011, 10.3727/096368910X539074.
164. Rafei M., Birman E., Forner K., Galipeau J. Allogeneic mesenchymal stem cells for treatment of experimental autoimmune encephalomyelitis. Mol. Ther. 2009, 17:1799-1803.
165. Ramon-Cueto A., Plant G.W., Avila J., Bunge M.B. Long-distance axonal regeneration in the transected adult rat spinal cord is promoted by olfactory ensheating glia transplants. J. Neurosci. 1998, 18:3803-3815.
166. Rha J.H., Saver J.L. The impact of recanalization on ischemic stroke outcome? A meta-analysis. Stroke 2007, 38:967-973.
167. Rehni A.K., Singh N., Jaggi A.S., Singh M. Amniotic fluid derived stem cells ameliorate focal cerebral ischaemia-reperfusion injury induced behavioural deficits in mice. Behav. Brain Res. 2007, 183:95-100.
168. Rodriguez A.I., Willing A.E., Saporta S., Cameron D.F., Sanberg P.R. Effects of Sertoli cell transplants in a 3-nitropropionic acid model of early Huntington's disease: a preliminary study. Neurotox. Res. 2003, 5:443-450.
169. Roy N.S., Cleren C., Singh S.K., et al. Functional engraftment of human ES cells-derived dopaminergic neurons enriched by co-culture with telomerase-immortalized midbrain astrocytes. Nat. Med. 2006, 12:1259-1268.
170. Ryu J.K., Cho T., Wang Y.T., McLarnon J.G. Neural progenitor cells attenuate inflammatory reactivity and neuronal loss in an animal model of inflamed AD brain. J. Neuroinflammation 2009, 6:39.
171. Saghatelyan A. Role of blood vessels in the neuronal migration. Semin. Cell Dev. Biol. 2009, 20:744-750.
172. Sanberg P.R., Borlongan C.V., Othberg A.I., et al. Testis-derived Sertoli cells have a trophic effect on dopamine neurons and alleviate hemiparkinsonism in rats. Nat. Med. 1997, 3:1129-1132.
173. Shi D., Chen G., Lv L., et al. The effect of lentivirus-mediated TH and GDNF genetic engineering mesenchymal stem cells on Parkinson's disease rat model. Neurol. Sci. 2010, 32:41-51.
174. Schwarting S., Litwak S., Hao W., et al. Hematopoietic stem cells reduce post-ischemic inflammation and ameliorate ischemic brain injury. Stroke 2008, 39:2867-2875.
175. Sensebé L., Bourin P., Tarte K. Good manufacturing practices production of mesenchymal stem/stromal cells. Hum. Gene Ther. 2011, 22:19-26.
176. Sieber-Blum M. Epidermal neural crest stem cells and their use in mouse models of spinal cord injury. Brain Res. Bull. 2010, 83:189-193.
177. Snyder B.R., Chiu A.M., Prockop D.J., Chan A.W. Human multipotent stromal cells (MSCs) increase neurogenesis and decrease atrophy of the striatum in a transgenic mouse model for Huntington's disease. PLoS One 2010, 5:e9347.
178. Somoza R., Juri C., Baes M., Wyneken U., Rubio F.J. Intranigral transplantation of epigenetically-induced BDNF-secreting human mesenchymal stem cells: implications for cell-based therapies in Parkinson's disease. Biol. Blood Marrow Transplant. 2010, 16:1530-1540.
179. Sun L., Lee J., Fine H.A. Neuronally expressed stem cell factor induces neural stem cell migration to areas of brain injury. J. Clin. Invest. 2004, 113:1364-1374.
180. Suzuki S., Tanaka K., Suzuki N. Ambivalent aspects of interleukin-6 in cerebral ischemia: inflammatory versus neurotrophic aspects. J. Cereb. Blood Flow Metab. 2009, 29:464-479.
181. Taguchi A., Soma T., Tanaka H., et al. Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J. Clin. Invest. 2004, 114:330-338.
182. Tai Y.F., Pavese N., Gerhard A., Tabrizi S.J., Barker R.A., Brooks D.J., Piccini P. Microglial activation in presymptomatic Huntington's disease gene carriers. Brain 2007, 130:1759-1766.
183. Takagi Y., Nishimura M., Morizane A., et al. Survival and differentiation of neural progenitor cells derived from embryonic cells and transplanted into ischemic brain. J. Neurosurg. 2005, 103:304-310.
184. Takano T., Oberheim N., Cotrina M.L., Nedergaard M. Astrocytes and ischemic injury. Stroke 2009, 40(Suppl. 3):S8-S12.
185. Tan K., Lessieur E., Cutler A., et al. Impaired function of circulating CD34(+) CD45(-) cells in patients with proliferative diabetic retinopathy. Exp. Eye Res. 2010, 91:229-237.
186. Tarella C., Rutella S., Gualandi F., et al. Consistent bone marrow-derived cell mobilization following repeated short courses of granulocyte-colony-stimulating factor in patients with amyotrophic lateral sclerosis: results from a multicenter prospective trial. Cytotherapy 2010, 12:50-59.
187. Taylor H.S. Endometrial cells derived from donor stem cells in bone marrow transplant recipients. JAMA 2004, 292:80-85.
188. Tissue plasminogen activator for acute ischemic stroke. N. Engl. J. Med. 1995, 333:1581-1587. The National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Study Group.
189. Tsuji O., Miura K., Okada Y., et al. Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injury. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:12704-12709.
190. Umemura T., Soga J., Hidaka T., et al. Aging and hypertension are independent risk factors for reduced number of circulating endothelial progenitor cells. Am. J. Hypertens. 2008, 21:1203-1209.
191. Vazey E.M., Dottori M., Jamshidi P., et al. Comparison of transplant efficiency between spontaneously-derived and Noggin-Primed human embryonic stem cell neural precursors in the Quinolinic acid rat model of Huntington's disease. Cell Transplant. 2010, 19:1055-1062.
192. Venkataramana N.K., Kumar S.K., Balaraju S., et al. Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson's disease. Transl. Res. 2010, 155:62-70.
193. Vercelli A., Mereuta O.M., Garbossa D., et al. Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis. Neurobiol. Dis. 2008, 31:395-405.
194. Wagner W., Bork S., Horn P., et al. Aging and replicative senescence have related effects on human stem and progenitor cells. PLoS One 2009, 4:e5846.
195. Wang X., Feuerstein G.Z., Xu L., et al. Inhibition of tumor necrosis factor-alpha-converting enzyme by a selective antagonist protects brain from focal ischemic injury in rats. Mol. Pharmacol. 2004, 65:890-896.
196. Wernig M., Zhao J., Pruszak J., et al. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:5856-5861.
197. Westrich J., Yaeger P., He C., et al. Factors affecting residence time of mesenchymal stromal cells (MSC) injected into the myocardium. Cell Transplant. 2010, 19:937-948.
198. Wolff E.F., Gao X.B., Yao K.V., et al. Endometrial stem cell transplantation restores dopamine production in a Parkinson's disease model. J. Cell. Mol. Med. 2011, 15:747-755.
199. Wu J., Sun Z., Sun H.S., et al. Intravenously administered bone marrow cells migrate to damaged brain tissue and improve neural function in ischemic rats. Cell Transplant. 2008, 16:993-1005.
200. Wu S., Sasaki A., Yoshimoto R., et al. Neural stem cells improve learning and memory in rats with Alzheimer's disease. Pathobiology 2008, 75:186-194.
201. Wyss-Coray T., Mucke L. Inflammation in neurodegenerative disease - a double edged sword. Neuron 2002, 35:419-432.
202. Xiong N., Cao X., Zhang Z., et al. Long-term efficacy and safety of human umbilical cord mesenchymal stromal cells in rotenone-induced hemiparkinsonian rats. Biol. Blood Marrow Transplant. 2010, 16:1519-1529.
203. Xu J., Kochanek K.D., Murphy S.L., Tejada-Vera B. Deaths, final data for 2007. Natl. Vital Stat. Rep. 2010, 57:1-134.
204. Xu L., Tan Y.Y., Ding J.Q., Chen S.D. The iPS technique provides hope for Parkinson's disease treatment. Stem Cell Rev. 2010, 6:398-404.
205. Xuan A.G., Luo M., Ji W.D., Long D.H. Effects of engrafted neural stem cells in Alzheimer's disease rats. Neurosci. Lett. 2009, 450:167-171.
206. Xuqian W., Kanghua L., Weihong Y., et al. Intraocular transplantation of human adipose-derived mesenchymal stem cells in a rabbit model of experimental retinal holes. Ophthalmic Res. 2011, 46:199-207.
207. Yagi H., Soto-Gutierrez A., Parekkadan B., et al. Mesenchymal stem cells: Mechanisms of immunomodulation and homing. Cell Transplant. 2010, 19:667-679.
208. Yamout B., Hourani R., Salti H., et al. Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: a pilot study. J. Neuroimmunol. 2010, 227:185-189.
209. Yang D., Zhang Z.J., Oldenburg M., Ayala M., Zhang S.C. Human embryonic stem cell-derived dopaminergic neurons reverse functional deficit in parkinsonian rats. Stem Cells 2008, 26:55-63.
210. Yang J.R., Liao C.H., Pang C.Y., et al. Directed differentiation into neural lineages and therapeutic potential of porcine embryonic stem cells in rat Parkinson's disease model. Cell. Reprogram. 2010, 12:447-461.
211. Yang X., Song L., Wu N., Liu Z., Xue S., Hui G. An experimental study on intracerebroventricular transplantation of human amniotic epithelial cells in a rat model of Parkinson's disease. Neurol. Res. 2010, 32(10):1054-1059.
212. Yasuhara T., Borlongan C.V., Date I. Ex vivo gene therapy: transplantation of neurotrophic factor-secreting cells for cerebral ischemia. Front Biosci. 2006, 11:760-775.
213. Yepes M., Roussel B.D., Ali C., Vivien D. Tissue-type plasminogen activator in the ischemic brain, more than a thrombolytic. Trends Neurosci. 2009, 32:48-55.
214. Yilmaz G., Granger D.N. Leukocyte recruitment and ischemic brain injury. Neuromolecular Med. 2010, 12:193-204.
215. Zhao C.P., Zhang C., Zhou S.N., et al. Human mesenchymal stromal cells ameliorate the phenotype of SOD1-G93A ALS mice. Cytotherapy 2007, 9:414-426.
216. Zhang M.J., Liu B., Xia W., Sun Z.Y., Lu K.H. Could cells from mentrual blood be a new source for cell-based therapies?. Med. Hypotheses 2009, 72:252-254.
217. Zhong Z., Patel A.N., Ichim T.E., et al. Feasibility investigation of allogeneic endometrial regenerative cells. J. Transl. Med. 2009, 7:15.
218. Zou Z., Jiang X., Zhang W., et al. Efficacy of Tyrosine Hydroxylase gene modified neural stem cells derived from bone marrow on Parkinson's disease-a rat model study. Brain Res. 2010, 1346:279-286.